Imidazoline RX871024 raises diacylglycerol levels in rat pancreatic islets

Alexander M. Efanov, Sergei V. Zaitsev, Per Olof Berggren, Hans Juergen Mest, Suad Efendic

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Imidazoline compound RX871024 and carbamylcholine (CCh) stimulate insulin secretion in isolated rat pancreatic islets. Combination of CCh and RX871024 induces a synergetic effect on insulin secretion. RX871024 and CCh produce twofold increases in diacylglycerol (DAG) concentration. The combination of two compounds has an additive effect on DAG concentration. Effects of RX871024 on insulin secretion and DAG concentration are not dependent on the presence of D609, an inhibitor of phosphatidylcholine-specific phospholipase C. It is concluded that as in case with CCh the increase in DAG concentration induced by imidazoline RX871024 contributes to the insulinotropic activity of the compound.

Original languageEnglish (US)
Pages (from-to)1070-1073
Number of pages4
JournalBiochemical and biophysical research communications
Volume281
Issue number5
DOIs
StatePublished - Jan 1 2001

Keywords

  • DAG
  • Imidazoline
  • Insulin secretion
  • Pancreatic islets

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Fingerprint Dive into the research topics of 'Imidazoline RX871024 raises diacylglycerol levels in rat pancreatic islets'. Together they form a unique fingerprint.

  • Cite this